- Home
- Publications
- Publication Search
- Publication Details
Title
The application of histone deacetylases inhibitors in glioblastoma
Authors
Keywords
-
Journal
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
Volume 39, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-07-18
DOI
10.1186/s13046-020-01643-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Tubastatin�A, an inhibitor of HDAC6, enhances temozolomide‑induced apoptosis and reverses the malignant phenotype of glioblastoma cells
- (2019) Alejandro Urdiciain et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- High-selective HDAC6 inhibitor promotes HDAC6 degradation following autophagy modulation and enhanced antitumor immunity in glioblastoma
- (2019) Jia-Rong Liu et al. BIOCHEMICAL PHARMACOLOGY
- Quercetin and Sodium Butyrate Synergistically Increase Apoptosis in Rat C6 and Human T98G Glioblastoma Cells Through Inhibition of Autophagy
- (2019) Matthew A. Taylor et al. NEUROCHEMICAL RESEARCH
- Histone Deacetylase Inhibitors Impair Vasculogenic Mimicry from Glioblastoma Cells
- (2019) Olga Pastorino et al. Cancers
- Discovery, structural insight, and bioactivities of BY27 as a selective inhibitor of the second bromodomains of BET proteins
- (2019) Deheng Chen et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- The synergistic effect of DZ‑NEP, panobinostat and temozolomide reduces clonogenicity and induces apoptosis in glioblastoma cells
- (2019) Javier De La Rosa et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- I-7ab inhibited the growth of TNBC cells via targeting HDAC3 and promoting the acetylation of p53
- (2018) Mei Yang et al. BIOMEDICINE & PHARMACOTHERAPY
- Combined HDAC and Bromodomain Protein Inhibition Reprograms Tumor Cell Metabolism and Elicits Synthetic Lethality in Glioblastoma
- (2018) Yiru Zhang et al. CLINICAL CANCER RESEARCH
- The first-in-class alkylating deacetylase inhibitor molecule tinostamustine shows antitumor effects and is synergistic with radiotherapy in preclinical models of glioblastoma
- (2018) Claudio Festuccia et al. Journal of Hematology & Oncology
- Chimeric HDAC inhibitors: Comprehensive review on the HDAC-based strategies developed to combat cancer
- (2018) Heba M. Hesham et al. MEDICINAL RESEARCH REVIEWS
- Modulation of nucleosomal DNA accessibility via charge-altering post-translational modifications in histone core
- (2018) Andrew T. Fenley et al. Epigenetics & Chromatin
- Targeting Histone Deacetylases with Natural and Synthetic Agents: An Emerging Anticancer Strategy
- (2018) Amit Singh et al. Nutrients
- The Promising Role of New Generation HDACis in Anti-Cancer Therapies
- (2018) Eric Hervouet EBioMedicine
- Inhibition of HDACs-EphA2 Signaling Axis with WW437 Demonstrates Promising Preclinical Antitumor Activity in Breast Cancer
- (2018) Tao Zhang et al. EBioMedicine
- Single agent efficacy of the HDAC inhibitor DATS in preclinical models of glioblastoma
- (2018) Arabinda Das et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Enhanced efficacy of histone deacetylase inhibitor combined with bromodomain inhibitor in glioblastoma
- (2018) Wei Meng et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- The synergistic effects of valproic acid and fluvastatin on apoptosis induction in glioblastoma multiforme cell lines
- (2017) Yung-Lung Chang et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Histone Deacetylase Inhibitors as Anticancer Drugs
- (2017) Tomas Eckschlager et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- A Mercaptoacetamide-Based Class II Histone Deacetylase Inhibitor Suppresses Cell Migration and Invasion in Monomorphic Malignant Human Glioma Cells by Inhibiting FAK/STAT3 Signaling
- (2017) Jin Han Nam et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Bromodomain Histone Readers and Cancer
- (2017) Abhinav K Jain et al. JOURNAL OF MOLECULAR BIOLOGY
- Phase I/II trial of vorinostat, bevacizumab, and daily temozolomide for recurrent malignant gliomas
- (2017) Katherine B. Peters et al. JOURNAL OF NEURO-ONCOLOGY
- LBH589 Inhibits Glioblastoma Growth and Angiogenesis Through Suppression of HIF-1α Expression
- (2017) Zhi-Gang Yao et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- JQ1 Induces DNA Damage and Apoptosis, and Inhibits Tumor Growth in a Patient-Derived Xenograft Model of Cholangiocarcinoma
- (2017) Patrick L. Garcia et al. MOLECULAR CANCER THERAPEUTICS
- Phase I/II trial of vorinostat combined with temozolomide and radiation therapy for newly diagnosed glioblastoma: results of Alliance N0874/ABTC 02
- (2017) Evanthia Galanis et al. NEURO-ONCOLOGY
- Phase II Study of Bevacizumab and Vorinostat for Patients with Recurrent World Health Organization Grade 4 Malignant Glioma
- (2017) Ashley Ghiaseddin et al. ONCOLOGIST
- Synergistic antitumor effects of the combined treatment with an HDAC6 inhibitor and a COX-2 inhibitor through activation of PTEN
- (2017) Guanhua Zhang et al. ONCOLOGY REPORTS
- Histone deacetylase inhibitors VPA and TSA induce apoptosis and autophagy in pancreatic cancer cells
- (2017) Maria Saveria Gilardini Montani et al. CELLULAR ONCOLOGY
- Advances in epigenetic glioblastoma therapy
- (2017) Dong Hoon Lee et al. Oncotarget
- FK228 augmented temozolomide sensitivity in human glioma cells by blocking PI3K/AKT/mTOR signal pathways
- (2016) YiHan Wu et al. BIOMEDICINE & PHARMACOTHERAPY
- The histone deacetylase inhibitor PCI-24781 as a putative radiosensitizer in pediatric glioblastoma cell lines
- (2016) Pamela Viani de Andrade et al. Cancer Cell International
- Silencing of histone deacetylase 2 suppresses malignancy for proliferation, migration, and invasion of glioblastoma cells and enhances temozolomide sensitivity
- (2016) Zhiqiang Zhang et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Histone deacetylase inhibitors suppress mutant p53 transcription via HDAC8/YY1 signals in triple negative breast cancer cells
- (2016) Zhao-Tong Wang et al. CELLULAR SIGNALLING
- Valproic acid reduces hair loss and improves survival in patients receiving temozolomide-based radiation therapy for high-grade glioma
- (2016) Shinichi Watanabe et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- ENGAGE- 501: phase II study of entinostat (SNDX-275) in relapsed and refractory Hodgkin lymphoma
- (2016) C. L. Batlevi et al. HAEMATOLOGICA
- Molecular and cellular effects of a novel hydroxamate-based HDAC inhibitor – belinostat – in glioblastoma cell lines: a preliminary report
- (2016) Magdalena Kusaczuk et al. INVESTIGATIONAL NEW DRUGS
- Enhanced efficacy of combined HDAC and PARP targeting in glioblastoma
- (2016) Rikke D. Rasmussen et al. Molecular Oncology
- Targeting the cancer epigenome for therapy
- (2016) Peter A. Jones et al. NATURE REVIEWS GENETICS
- Histone Deacetylase Inhibitor RGFP109 Overcomes Temozolomide Resistance by Blocking NF-κB-Dependent Transcription in Glioblastoma Cell Lines
- (2016) Zong-yang Li et al. NEUROCHEMICAL RESEARCH
- Functional interaction of histone deacetylase 5 (HDAC5) and lysine-specific demethylase 1 (LSD1) promotes breast cancer progression
- (2016) C Cao et al. ONCOGENE
- Inhibition of histone deacetylases sensitizes glioblastoma cells to lomustine
- (2016) Mikkel Staberg et al. CELLULAR ONCOLOGY
- ENGAGE- 501: phase II study of entinostat (SNDX-275) in relapsed and refractory Hodgkin lymphoma
- (2016) C. L. Batlevi et al. HAEMATOLOGICA
- A novel class I histone deacetylase inhibitor, I-7ab, induces apoptosis and arrests cell cycle progression in human colorectal cancer cells
- (2015) Liyan Yang et al. BIOMEDICINE & PHARMACOTHERAPY
- Protein Lysine Acetylation by p300/CBP
- (2015) Beverley M. Dancy et al. CHEMICAL REVIEWS
- Molecular targets in glioblastoma
- (2015) Maira Zorzan et al. Future Oncology
- A Phase 2 Study of Concurrent Radiation Therapy, Temozolomide, and the Histone Deacetylase Inhibitor Valproic Acid for Patients With Glioblastoma
- (2015) Andra V. Krauze et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Histone Deacetylase Inhibitors in Clinical Studies as Templates for New Anticancer Agents
- (2015) Madhusoodanan Mottamal et al. MOLECULES
- Phase II study of panobinostat in combination with bevacizumab for recurrent glioblastoma and anaplastic glioma
- (2015) E. Q. Lee et al. NEURO-ONCOLOGY
- Preclinical activity of combined HDAC and KDM1A inhibition in glioblastoma
- (2015) Melissa M. Singh et al. NEURO-ONCOLOGY
- The HDAC Inhibitors Scriptaid and LBH589 Combined with the Oncolytic Virus Delta24-RGD Exert Enhanced Anti-Tumor Efficacy in Patient-Derived Glioblastoma Cells
- (2015) Lotte M.E. Berghauser Pont et al. PLoS One
- The Bromodomain protein BRD4 controls HOTAIR, a long noncoding RNA essential for glioblastoma proliferation
- (2015) Chiara Pastori et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Histone Deacetylase Inhibitors Resensitize EGFR/EGFRvIII-Overexpressing, Erlotinib-Resistant Glioblastoma Cells to Tyrosine Kinase Inhibition
- (2015) Katrin Liffers et al. Targeted Oncology
- Phenylbutyrate—a pan-HDAC inhibitor—suppresses proliferation of glioblastoma LN-229 cell line
- (2015) Magdalena Kusaczuk et al. TUMOR BIOLOGY
- HDAC9 promotes glioblastoma growth via TAZ-mediated EGFR pathway activation
- (2015) Rui Yang et al. Oncotarget
- HDAC Inhibition Upregulates PD-1 Ligands in Melanoma and Augments Immunotherapy with PD-1 Blockade
- (2015) D. M. Woods et al. Cancer Immunology Research
- Current Challenges in Glioblastoma: Intratumour Heterogeneity, Residual Disease, and Models to Predict Disease Recurrence
- (2015) Hayley P. Ellis et al. Frontiers in Oncology
- BET bromodomain proteins are required for glioblastoma cell proliferation
- (2014) Chiara Pastori et al. Epigenetics
- Regulation of Histone Acetyltransferase TIP60 Function by Histone Deacetylase 3
- (2014) Jingjie Yi et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The Effects of Histone Deacetylase Inhibitors on Glioblastoma-Derived Stem Cells
- (2014) Angel A. Alvarez et al. JOURNAL OF MOLECULAR NEUROSCIENCE
- Histone deacetylase inhibitors in glioblastoma: pre-clinical and clinical experience
- (2014) Pavel Bezecny MEDICAL ONCOLOGY
- Histone core modifications regulating nucleosome structure and dynamics
- (2014) Peter Tessarz et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- 50 years of protein acetylation: from gene regulation to epigenetics, metabolism and beyond
- (2014) Eric Verdin et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- The Role of Dietary Histone Deacetylases (HDACs) Inhibitors in Health and Disease
- (2014) Shalome Bassett et al. Nutrients
- Suberoylanilide hydroxamic acid (SAHA) causes tumor growth slowdown and triggers autophagy in glioblastoma stem cells
- (2013) Ming-Tsang Chiao et al. Autophagy
- The physiological roles of histone deacetylase (HDAC) 1 and 2: complex co-stars with multiple leading parts
- (2013) Richard D.W. Kelly et al. BIOCHEMICAL SOCIETY TRANSACTIONS
- Histones and lung cancer: are the histone deacetylases a promising therapeutic target?
- (2013) Vasiliki Petta et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- The promise and failures of epigenetic therapies for cancer treatment
- (2013) Pasano Bojang et al. CANCER TREATMENT REVIEWS
- Valproic Acid Use During Radiation Therapy for Glioblastoma Associated With Improved Survival
- (2013) Christopher A. Barker et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- HDAC inhibitor DWP0016 activates p53 transcription and acetylation to inhibit cell growth in U251 glioblastoma cells
- (2013) Hui Jin et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Histone Deacetylases
- (2013) Sabnam Parbin et al. JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY
- Multi-targeted DATS prevents tumor progression and promotes apoptosis in ectopic glioblastoma xenografts in SCID mice via HDAC inhibition
- (2013) Gerald C. Wallace et al. JOURNAL OF NEURO-ONCOLOGY
- Histone Deacetylase Inhibitors Potentiate Vesicular Stomatitis Virus Oncolysis in Prostate Cancer Cells by Modulating NF- B-Dependent Autophagy
- (2013) L. Shulak et al. JOURNAL OF VIROLOGY
- Histone deacetylase 3 as a novel therapeutic target in multiple myeloma
- (2013) J Minami et al. LEUKEMIA
- Comparing Histone Deacetylase Inhibitor Responses in Genetically Engineered Mouse Lung Cancer Models and a Window of Opportunity Trial in Patients with Lung Cancer
- (2013) T. Ma et al. MOLECULAR CANCER THERAPEUTICS
- Potential Advantages of CUDC-101, a Multitargeted HDAC, EGFR, and HER2 Inhibitor, in Treating Drug Resistance and Preventing Cancer Cell Migration and Invasion
- (2013) J. Wang et al. MOLECULAR CANCER THERAPEUTICS
- Inhibition of Histone Deacetylase 3 Causes Replication Stress in Cutaneous T Cell Lymphoma
- (2013) Christina E. Wells et al. PLoS One
- HDAC inhibitors and their potential applications to glioblastoma therapy
- (2013) Eleni Adamopoulou et al. OncoImmunology
- Phase I Study of Vorinostat in Combination with Temozolomide in Patients with High-Grade Gliomas: North American Brain Tumor Consortium Study 04-03
- (2012) E. Q. Lee et al. CLINICAL CANCER RESEARCH
- Understanding Histone Deacetylases in the Cancer Development and Treatment: An Epigenetic Perspective of Cancer Chemotherapy
- (2012) Mudassier Ahmad et al. DNA AND CELL BIOLOGY
- Concerted action of the PHD, chromo and motor domains regulates the human chromatin remodelling ATPase CHD4
- (2012) Rosa Morra et al. FEBS LETTERS
- Evaluation of safety, pharmacokinetics, and efficacy of vorinostat, a histone deacetylase inhibitor, in the treatment of gastrointestinal (GI) cancer in a phase I clinical trial
- (2012) Toshihiko Doi et al. International Journal of Clinical Oncology
- Rationale for the Development of 2-Aminobenzamide Histone Deacetylase Inhibitors as Therapeutics for Friedreich Ataxia
- (2012) Elisabetta Soragni et al. JOURNAL OF CHILD NEUROLOGY
- Rapid Discovery of Highly Potent and Selective Inhibitors of Histone Deacetylase 8 Using Click Chemistry to Generate Candidate Libraries
- (2012) Takayoshi Suzuki et al. JOURNAL OF MEDICINAL CHEMISTRY
- P53-dependent antiproliferative and pro-apoptotic effects of trichostatin A (TSA) in glioblastoma cells
- (2012) K. Bajbouj et al. JOURNAL OF NEURO-ONCOLOGY
- HDAC inhibitor-based therapies: Can we interpret the code?
- (2012) Maria New et al. Molecular Oncology
- Epigenetic protein families: a new frontier for drug discovery
- (2012) Cheryl H. Arrowsmith et al. NATURE REVIEWS DRUG DISCOVERY
- Class I Histone Deacetylase Inhibitor Entinostat Suppresses Regulatory T Cells and Enhances Immunotherapies in Renal and Prostate Cancer Models
- (2012) Li Shen et al. PLoS One
- Chemosensitization of glioblastoma cells by the histone deacetylase inhibitor MS275
- (2011) Annette Bangert et al. ANTI-CANCER DRUGS
- Enhanced effects by 4-phenylbutyrate in combination with RTK inhibitors on proliferation in brain tumor cell models
- (2011) Ana-Maria Marino et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Regulation of chromatin by histone modifications
- (2011) Andrew J Bannister et al. CELL RESEARCH
- Rational therapeutic combinations with histone deacetylase inhibitors for the treatment of cancer
- (2011) K Ted Thurn et al. Future Oncology
- NBM-HD-3, a novel histone deacetylase inhibitor with anticancer activity through modulation of PTEN and AKT in brain cancer cells
- (2011) Wei-Jan Huang et al. JOURNAL OF ETHNOPHARMACOLOGY
- Mocetinostat for relapsed classical Hodgkin's lymphoma: an open-label, single-arm, phase 2 trial
- (2011) Anas Younes et al. LANCET ONCOLOGY
- Tubacin suppresses proliferation and induces apoptosis of acute lymphoblastic leukemia cells
- (2011) Grace I. Aldana-Masangkay et al. LEUKEMIA & LYMPHOMA
- Phase II trial of vorinostat in combination with bortezomib in recurrent glioblastoma: a north central cancer treatment group study
- (2011) B. B. Friday et al. NEURO-ONCOLOGY
- Phase I trial of vorinostat combined with bevacizumab and CPT-11 in recurrent glioblastoma
- (2011) Prakash Chinnaiyan et al. NEURO-ONCOLOGY
- Inhibition of LSD1 sensitizes glioblastoma cells to histone deacetylase inhibitors
- (2011) M. M. Singh et al. NEURO-ONCOLOGY
- A phase I/II trial of the histone deacetylase inhibitor romidepsin for adults with recurrent malignant glioma: North American Brain Tumor Consortium Study 03-03
- (2011) Fabio M. Iwamoto et al. NEURO-ONCOLOGY
- The Mechanism of Action of the Histone Deacetylase Inhibitor Vorinostat Involves Interaction with the Insulin-Like Growth Factor Signaling Pathway
- (2011) Rive Sarfstein et al. PLoS One
- Histone deacetylases as regulators of inflammation and immunity
- (2011) Melanie R. Shakespear et al. TRENDS IN IMMUNOLOGY
- Inhibition of SIRT1 by a small molecule induces apoptosis in breast cancer cells
- (2010) Arunasree M. Kalle et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Phase 1 Study of Valproic Acid in Pediatric Patients with Refractory Solid or CNS Tumors: A Children's Oncology Group Report
- (2010) J. M. Su et al. CLINICAL CANCER RESEARCH
- Inside HDAC with HDAC inhibitors
- (2010) Philippe Bertrand EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Final Results From a Multicenter, International, Pivotal Study of Romidepsin in Refractory Cutaneous T-Cell Lymphoma
- (2010) Sean J. Whittaker et al. JOURNAL OF CLINICAL ONCOLOGY
- Discovery of 7-(4-(3-Ethynylphenylamino)-7-methoxyquinazolin-6-yloxy)-N-hydroxyheptanamide (CUDC-101) as a Potent Multi-Acting HDAC, EGFR, and HER2 Inhibitor for the Treatment of Cancer
- (2010) Xiong Cai et al. JOURNAL OF MEDICINAL CHEMISTRY
- Vorinostat enhances the cytotoxic effects of the topoisomerase I inhibitor SN38 in glioblastoma cell lines
- (2010) Bhaswati Sarcar et al. JOURNAL OF NEURO-ONCOLOGY
- Selective inhibition of BET bromodomains
- (2010) Panagis Filippakopoulos et al. NATURE
- Enhancer of Zeste 2 (EZH2) is up-regulated in malignant gliomas and in glioma stem-like cells
- (2010) F. Orzan et al. NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY
- Genome-wide Loss-of-Function Screen Reveals an Important Role for the Proteasome in HDAC Inhibitor-Induced Apoptosis
- (2009) Susan Fotheringham et al. CANCER CELL
- Histone deacetylase inhibitors as anti-neoplastic agents
- (2009) Nicolas Batty et al. CANCER LETTERS
- HDAC inhibitor, scriptaid, induces glioma cell apoptosis through JNK activation and inhibits telomerase activity
- (2009) Vivek Sharma et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Phase II Trial of Vorinostat in Recurrent Glioblastoma Multiforme: A North Central Cancer Treatment Group Study
- (2009) Evanthia Galanis et al. JOURNAL OF CLINICAL ONCOLOGY
- Novel Cambinol Analogs as Sirtuin Inhibitors: Synthesis, Biological Evaluation, and Rationalization of Activity
- (2009) Federico Medda et al. JOURNAL OF MEDICINAL CHEMISTRY
- A Histone Deacetylase Inhibitor LBH589 Downregulates XIAP in Mesothelioma Cell Lines Which is Likely Responsible for Increased Apoptosis With TRAIL
- (2009) James Symanowski et al. Journal of Thoracic Oncology
- Tip60-ing the balance in DSB repair
- (2009) Wolfgang Fischle NATURE CELL BIOLOGY
- Epigenetic mechanisms in glioblastoma multiforme
- (2009) Raman P. Nagarajan et al. SEMINARS IN CANCER BIOLOGY
- Class II histone deacetylases play pivotal roles in heat shock protein 90-mediated proteasomal degradation of vascular endothelial growth factor receptors
- (2008) Jung-Hyun Park et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Class I Histone Deacetylase Expression Has Independent Prognostic Impact in Human Colorectal Cancer: Specific Role of Class I Histone Deacetylases In vitro and In vivo
- (2008) W. Weichert et al. CLINICAL CANCER RESEARCH
- A novel histone deacetylase 8 (HDAC8)-specific inhibitor PCI-34051 induces apoptosis in T-cell lymphomas
- (2008) S Balasubramanian et al. LEUKEMIA
- The many roles of histone deacetylases in development and physiology: implications for disease and therapy
- (2008) Michael Haberland et al. NATURE REVIEWS GENETICS
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started